Family Medicine Doctors in Crow Agency, MT Accepting Medicare

4 Family Medicine doctors found. Showing 1 - 4

Nipa Hitendra Sinh, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10110 South 7650 East, Crow Agency, MT 59022 Phone: 406-638-3500

Dr. Bella Marie Gentry, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13 E Makpas Ave, Crow Agency, MT 59022 Phone: 406-638-3300

Dr. Geraldine Bernice Mournian, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10110 S 7650 E, Phs Indian Hospital, Crow Agency, MT 59022 Phone: 406-638-3300    Fax: 406-638-3572

James David Upchurch, Family Medicine Medicare: Medicare Enrolled Practice Location: 10110 S 7650 E, Crow Northern Cheyenne Indian Hospital, Crow Agency, MT 59022 Phone: 406-638-3442    Fax: 406-638-3482

News Archive

Community support critical for reducing childhood obesity

Community support of school obesity prevention programs is critical to achieving a significant decrease in obesity among children, according to researchers at the Michael & Susan Dell Center for Advancement of Healthy Living, which is part of The University of Texas Health Science Center at Houston (UTHealth).

Zeria to market, distribute, and sell HemCon's wound and oral care dressings in Japan

HemCon Medical Technologies, Inc., an innovative developer of advanced medical products, is proud to announce the signing of an exclusive licensing agreement with Zeria Pharmaceuticals Co. Ltd., a leading pharmaceutical and consumer healthcare products company. Through this partnership, Zeria will market, distribute, and sell HemCon's line of revolutionary wound and oral care dressings throughout Japan.

SARS-CoV-2 clade linked to disease severity in the early phase of the pandemic

A new study in the journal JAMA Network reports on the disease severity associated with some clades of the virus, from an analysis of genomes from specimens isolated in the initial phase of the pandemic.

Pfizer, Wyeth and PF Prism file suit against Watson over generic Pristiq

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Desvenlafaxine Succinate Extended-release Tablets, 50 mg and 100 mg.

Read more Medical News

› Verified 1 days ago